.png)
Drug development is increasingly complex, requiring rapid, informed decision-making throughout the product life cycle and across manufacturing sites. Access to a broad, deep scientific pool of pharmaceutical development expertise is especially critical when developing novel therapies, formulating for targeted patient groups, and dealing with technical challenges that can arise without warning.
Starting from a previously validated molecule is one of the fastest ways to reach the clinic, but the IP economics are unforgiving. Molecules that closely track prior art offer weak IP protection, and method-of-use claims often fail to defend a market position.
.jpg)
Spray drying is a versatile pharmaceutical manufacturing technique that converts liquid formulations into dry powders, enabling drug developers to enhance bioavailability, engineer particle properties, and handle complex molecules safely and efficiently.
Starting materials are vital to the reliable supply of high-quality medicines. As critical building blocks of active pharmaceutical ingredients (APIs), these materials influence everything from product purity to supply chain security.
Extractables and leachables (E&L) represent an important class of impurities in pharmaceutical products that can arise from interactions between drug formulations and packaging materials, manufacturing components, or delivery devices, and migrate into drug products during manufacturing, storage, or administration.
-1-1.png)
-3.png)
-2-1.png)
-2.png)
.png)
